NFKB1 and Alzheimer disease: A possible role of TG2-mediated NF-κB activation pathway, the main regulator of inflammation, was suggested in the pathogenesis of Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and amyotrophic lateral sclerosis [35].